Johnson & Johnson will become the first drug maker to begin showing the list price of its prescription drugs in television ads; in a 5-4 decision, the Supreme Court blocked a Louisiana law that required doctors performing abortions to have admitting privileges at nearby hospitals; Democrats unveiled a bill to allow Medicare to negotiate drug prices.
Johnson & Johnson will become the first drug maker to begin showing the list price of its prescription drugs in television ads, the Associated Press reported. The first drug it will start with is its blood thinner Xarelto. By late March, commercials will give the pill’s list price plus typical out-of-pocket costs.
In a 5-4 decision, the Supreme Court blocked a Louisiana law that required doctors performing abortions to have admitting privileges at nearby hospitals, The New York Times reported. Opponents of the law said it could have left the state with just 1 doctor authorized to provide abortions. Chief Justice John G. Roberts Jr joined the court’s 4-member liberal wing.
Led by Senator Sherrod Brown, D-Ohio, who is considering a presidential run, Democrats unveiled a bill to allow Medicare to negotiate drug prices, a key part of their agenda to lower pharmaceutical costs. Joined by Representative Lloyd Doggett, D-Texas, the chairman of the House Ways and Means Health Subcommittee, Brown said he hoped that President Trump would listen to “candidate Trump,” referring to when Trump said during his campaign that he supported the idea, before reversing his position. The bill has long odds of passage, The Hill noted.
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Health Equity & Access Weekly Roundup: November 2, 2024
November 2nd 2024This week’s Center on Health Equity & Access highlights emphasize the role of social determinants of health in policy-making and underscore the importance of addressing rising costs and challenges employers face.
Read More